HLN

Haleon files as a foreign private issuer (latest disclosure is a 6-K dated 2026-06-15, not a 10-K/10-Q), so the SEC XBRL set here is bare: the only hard fundamental provided is shares outstanding of 8.95B, down 1.4% year-over-year. That decline is the one constructive signal in the data — a shrinking count is consistent with an active buyback returning capital and modestly lifting per-share claims on earnings. But a falling share count tells you nothing about the underlying business quality on its own.

Critically, none of the inputs the methodology requires are present: there is no revenue, no margin trend, no operating profit, no debt or cash balance, and no ROE. Without revenue and earnings I cannot compute a P/E, P/S, or any growth-adjusted multiple, so the $8.96 price (up 1.01% today) cannot be related to the fundamentals at all. Valuation is genuinely unknowable from this data, not merely uncertain.